Polar Capital Holdings’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-928,745
| Closed | -$66.5M | – | 308 |
|
|
2023
Q4 | $66.5M | Sell |
928,745
-71,255
| -7% | -$5.1M | 0.41% | 69 |
|
|
2023
Q3 | $52.1M | Buy |
1,000,000
+600,000
| +150% | +$31.3M | 0.39% | 76 |
|
|
2023
Q2 | $25.3M | Hold |
400,000
| – | – | 0.13% | 126 |
|
|
2023
Q1 | $21.7M | Sell |
400,000
-48,580
| -11% | -$2.63M | 0.14% | 132 |
|
|
2022
Q4 | $23.7M | Sell |
448,580
-155,670
| -26% | -$8.24M | 0.19% | 133 |
|
|
2022
Q3 | $28.1K | Sell |
604,250
-284,287
| -32% | -$13.2K | 0.18% | 114 |
|
|
2022
Q2 | $50.7K | Buy |
888,537
+367,094
| +70% | +$21K | 0.3% | 77 |
|
|
2022
Q1 | $31.9K | Buy |
521,443
+429,708
| +468% | +$26.3K | 0.14% | 127 |
|
|
2021
Q4 | $4.8K | Hold |
91,735
| – | – | 0.02% | 258 |
|
|
2021
Q3 | $3.42K | Buy |
91,735
+33,291
| +57% | +$1.24K | 0.01% | 290 |
|
|
2021
Q2 | $2.39K | Buy |
+58,444
| New | +$2.39K | 0.01% | 297 |
|
|
2021
Q1 | – | Sell |
-10,558
| Closed | -$336K | – | 353 |
|
|
2020
Q4 | $336K | Buy |
+10,558
| New | +$336K | ﹤0.01% | 311 |
|